MRNA vs AAPL: Which Stock is Better?
Side-by-side comparison of MRNA and Apple Inc in 2026
Comparison Updated:
MRNA
MRNA
$0.00
AAPL
Apple Inc
$260.25
Key Metrics Comparison
| Metric | MRNA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $0.00M | $3.86T | AAPL |
| P/E Ratio | N/A | 33.85 | MRNA |
| EPS (TTM) | $N/A | $7.55 | AAPL |
| Revenue Growth | 0.0% | 6.4% | AAPL |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze MRNA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MRNA or AAPL a better investment?
Comparing MRNA and AAPL: MRNA has a market cap of $0.00M while Apple Inc has $3.86T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MRNA and AAPL?
MRNA (MRNA) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MRNA or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.